Wed. 28 Feb 2024, 6:38am ET
Benzinga
Earnings, News
G1 Therapeutics (NASDAQ:GTHX) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.28) by 25 percent. This is a 71.23 percent increase over losses of $(0.73) per share from the same period last year. The company reported quarterly sales of $14.87 million which beat the analyst consensus estimate of $13.08 million by 13.72 percent. This is a 45.10 percent increase over sales of $10.25 million the same period last year.